New Viral Vector May Make Gene Therapy for Sickle Cell More Effective, NIH Study Reports
A newly designed viral vector — the vehicle that delivers a gene therapy to a patient’s cells — for use in sickle cell anemia is more efficient than earlier vectors at introducing healthy copies of genes into stem cells and can be produced in greater amounts, studies in animal models…